Evidence map›Paper›PMID 21046408›Full record

ReviewActa neuropathologica2011

Role of cytoskeletal abnormalities in the neuropathology and pathophysiology of type I lissencephaly.

Gaëlle Friocourt, Pascale Marcorelles, Pascale Saugier-Veber, Marie-Lise Quille, Stephane Marret, Annie Laquerrière

Open access · hybridAbstract readReview
In one paragraph

Review in Acta neuropathologica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Comprehensive genotype-phenotype correlation in lissencephaly.Quantitative imaging in medicine and surgery · 2018
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Gaëlle FriocourtInserm, U613, Brest, France.
Pascale Marcorelles
Pascale Saugier-Veber
Marie-Lise Quille
Stephane Marret
Annie Laquerrière
Inserm · FRCentre Hospitalier Régional Universitaire de Brest · FRHôpital Charles-Nicolle · FRUniversité de Rouen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type I lissencephaly or agyria-pachygyria is a rare developmental disorder which results from a defect of neuronal migration. It is characterized by the absence of gyri and a thickening of the cerebral cortex and can be associated with other brain and visceral anomalies. Since the discovery of the first genetic cause (deletion of chromosome 17p13.3), six additional genes have been found to be responsible for agyria-pachygyria. In this review, we summarize the current knowledge concerning these genetic disorders including clinical, neuropathological and molecular results. Genetic alterations of LIS1, DCX, ARX, TUBA1A, VLDLR, RELN and more recently WDR62 genes cause migrational abnormalities along with more complex and subtle anomalies affecting cell proliferation and differentiation, i.e., neurite outgrowth, axonal pathfinding, axonal transport, connectivity and even myelination. The number and heterogeneity of clinical, neuropathological and radiological defects suggest that type I lissencephaly now includes several forms of cerebral malformations. In vitro experiments and mutant animal studies, along with neuropathological abnormalities in humans are of invaluable interest for the understanding of pathophysiological mechanisms, highlighting the central role of cytoskeletal dynamics required for a proper achievement of cell proliferation, neuronal migration and differentiation.

Indexed as

BrainCytoskeleton1-Alkyl-2-acetylglycerophosphocholine EsteraseCell Cycle ProteinsCell MovementCell ProliferationClassical Lissencephalies and Subcortical Band HeterotopiasDiagnostic ImagingDoublecortin Domain ProteinsDoublecortin ProteinFemaleHomeodomain ProteinsHumansMaleMicrotubule-Associated ProteinsModels, Biological1-Alkyl-2-acetylglycerophosphocholine EsteraseARX protein, humanCell Cycle ProteinsDCX protein, humanDoublecortin Domain ProteinsDoublecortin ProteinHomeodomain ProteinsMicrotubule-Associated ProteinsNerve Tissue ProteinsNeuropeptidesPAFAH1B1 protein, humanReelin ProteinRELN protein, humanTranscription FactorsTUBA1A protein, humanTubulinWDR62 protein, human

Identifiers

PMID21046408
PMCPMC3037170
OpenAlexW2042357077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.